Also visit: Campus Mixxer | Boxxet
 

For Profit, Industry Seeks Cancer Drugs external link

New York Times | Tue, Sep 1

The drug Tarceva, which costs about $3500 a month, was approved as a treatment for pancreatic cancer because it improved survival by 12 days. ...

and more »

[Read original...]

Try These Related Topics

 
 
 

Do you publish a blog? If so, consider joining the Boxxet Network and see your great content showcased and rewarded! Learn more...

©2009 Boxxet, Inc. | Contact | Privacy Policy | Terms of Service
Page updated Mon, Jan 18.